Holen Sie sich die Stockscreener-App
839.96
14.30%
105.06
Handel nachbörslich:
844.00
4.04
+0.48%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Lilly Blasts Compounders' 'Scattershot' Bid To Reverse FDA - Law360
Eli Lilly (LLY) Boosts U.S. Manufacturing with Promising Weight-Loss Pill - GuruFocus
Eli Lilly plans to make weight-loss pill in U.S. amid Trump’s reshoring push (NYSE:LLY) - Seeking Alpha
Eli Lilly (NYSE:LLY) Advances Diabetes Treatment And Partners With BigHat On Antibody Discovery - Yahoo Finance
Lilly says new daily pill can help with weight loss, blood sugar - NewsNation
Daily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly Says - Verywell Health
First Weight-Loss Pill From Lilly Shows Promising Results - Wyoming Tribune Eagle
Lilly Promises to Make Weight-Loss Pill in US in Reshoring Push - Bloomberg.com
Eli Lilly and Company (LLY): One of the Best Long Term Stocks to Buy According to Billionaires - Insider Monkey
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal - Pharmaceutical Technology
Top-Line Results Positive for Lilly’s Oral Orforglipron - Medscape
Lilly's orforglipron consistent with injectable GLP-1 medicines in Phase 3 trial - MSN
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar - The New York Times
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025) - 24/7 Wall St.
Where Will Eli Lilly Be in 5 Years? - The Motley Fool
Atopic Dermatitis Drugs Market Forecast 2025-2034 | Rising Drug Approvals and Clinical Trial Successes Propel Revenue Growth, Making Atopic Dermatitis a High-Growth Market - GlobeNewswire Inc.
Why Eli Lilly and Company (LLY) is Skyrocketing? - Insider Monkey
Eli Lilly (LLY) Surges on Promising Obesity Pill Trial Results - GuruFocus
Eli Lilly develops groundbreaking new weight-loss pill - NBC News
Eli Lilly (LLY) Shares Surge on Promising New Weight-Loss Pill - GuruFocus
Lilly Soars After Pill Shows Its as Good as Ozempic - Bloomberg.com
Eli Lilly's obesity drug trial shows 7.3kg weight loss, boosts market competitionCHOSUNBIZ - Chosunbiz
Friday Five – Lilly's obesity oral could eat up competition, pill penalty pivot, tariff talk…and more - FirstWord Pharma
Experimental GLP-1 pill helped people with diabetes lose weight and lower blood sugar, Eli Lilly says - WTOP
Chugai Highlights Eli Lilly’s Promising Phase 3 Results for Orforglipron - TipRanks
Eli Lilly and Co (LLY) Stock Price, Trades & News - GuruFocus
Eli Lilly: Experimental GLP-1 pill for diabetes helped with weight loss, blood sugar - Yahoo
Post-Pfizer dropout, Lilly Achieves GLP-1 win in phase III - BioWorld MedTech
Eli Lilly shares jump 14% on positive results for its ’Ozempic in a pill’ - Investing.com
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React - Benzinga
Lilly weight-loss pill works as well as Ozempic, shares surge - MSN
How Eli Lilly's GLP-1 pill could transform the weight-loss space - Yahoo Finance
Eli Lilly's Obesity Trial Triumph Boosts Shares, While UnitedHealth Stumbles - Finimize
U.S. Markets Closed Mixed Thursday As Eli Lilly Led, Webull Lagged - Barron's
Lilly soars after weight-loss pill results rival Ozempic’s - The Detroit News
Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock - Benzinga
Lilly says new weight loss, diabetes drug in pill form could be game changer - Deseret News
Eli Lilly’s stock soars 13% after reporting positive data from trial of diabetes and weight-loss pill - MSN
Daily GLP-1 pill effective for diabetes and obesity, Eli Lilly says - AOL.com
Weight-loss drug news sends Eli Lilly stock soaring - TheStreet
Lilly shares soar on new weight-loss pill that looks to pass Ozempic - Orange County Register
Lilly’s First Pill for Diabetes, Weight Loss Shows Positive Study Results - WSJ
Novo Nordisk Stock Drops on Eli Lilly Oral Weight-Loss Drug Success, Downgrade - Yahoo Finance
Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms - MSN
New Eli Lilly-made GLP-1 pill could work as well as its injectable Mounjaro, Zepbound - Washington Times
Eli Lilly daily diabetes pill could be as effective as Ozempic and Mounjaro, trial finds - Spectrum News
Lilly's Diabetes Pill Clears Major Trial, Analyst Points To Global Potential - Benzinga
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide - Yahoo
Lilly’s obesity pill scores in large diabetes trial - BioPharma Dive
Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic - New York Post
Eli Lilly's new GLP-1 weight loss pill showed success in clinical trial - LiveNOW from FOX
Why Is Eli Lilly (LLY) Stock Rocketing Higher Today - Yahoo Finance
Eli Lilly Weight Loss Pill Is A GLP-1 Drug Without Injections - TODAY.com
Lilly Soars As Study Shows Weight-Loss Pill to Pass Ozempic - Yahoo Finance
Lilly Weight-Loss Pill Works as Well as Ozempic, Shares Surge - GV Wire
Market movers: UnitedHealth, Eli Lilly, Hertz, ReconAfrica... - Proactive Investors
Lilly’s Weight-Loss Pill Shakes Up the Market: What You Need to Know - RagingBull
Eli Lilly finds its weight-loss pill works just as well as Ozempic — and investors are loving it - AOL.com
Eli Lilly stock spikes as efficacy of new weight-loss pill rivals Ozempic - Dallas News
Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars - Quartz
UnitedHealth tumbles, Eli Lilly climbs, TSMC holds outlook - Yahoo Finance
2.31%
7.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):